Your session is about to expire
← Back to Search
Biospecimen Collection for Peritoneal Cancer
N/A
Recruiting
Led By Maheswari Senthil, MD FACS
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 years
Awards & highlights
Study Summary
This trial is researching the causes of gastrointestinal cancer. Patients provide blood, tumor samples, and fluids for study.
Who is the study for?
This trial is for adults over 18 with peritoneal carcinomatosis originating from gastrointestinal tumors, who are scheduled for standard surgical procedures. They must be able to understand and sign consent forms. Those unable to follow the study protocol cannot participate.Check my eligibility
What is being tested?
The study involves collecting biospecimens such as blood, ascites/peritoneal wash fluid, and tumor samples during planned surgeries of patients with gastrointestinal peritoneal carcinomatosis.See study design
What are the potential side effects?
Since this trial focuses on sample collection rather than drug testing, there are no direct side effects related to medications. However, typical risks associated with surgical procedures may apply.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 4 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Development of individual patient-derived peritoneal carcinomatosis (pdPC) vascularized micro-tumor (VMT)
Establishment of angioarchitechture of peritoneal lesions through Optical Coherence Tomography Angiography (OCTA)
Secondary outcome measures
Compare response of therapeutic regimens in a pdPC VMT to the observed clinical response (by RECIST criteria or diagnostic laparoscopy)
Overall Survival (OS)
Progression-Free Survival (PFS) at 6 months
Trial Design
1Treatment groups
Experimental Treatment
Group I: Subjects with Gastrointestinal Peritoneal CarcinomatosisExperimental Treatment1 Intervention
Subjects with gastrointestinal (GI) peritoneal carcinomatosis who are undergoing planned standard of care (SOC) surgical procedures. Biospecimens such as blood, peritoneal wash fluid and tumor samples will be obtained.
Find a Location
Who is running the clinical trial?
University of California, IrvineLead Sponsor
544 Previous Clinical Trials
1,923,023 Total Patients Enrolled
1 Trials studying Peritoneal Carcinomatosis
35 Patients Enrolled for Peritoneal Carcinomatosis
Maheswari Senthil, MD FACSPrincipal InvestigatorChao Family Comprehensive Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My cancer started in the GI tract and has spread to the lining of my abdomen.I am scheduled for a standard surgery recommended for my condition.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Subjects with Gastrointestinal Peritoneal Carcinomatosis
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research endeavor currently have open enrollment?
"Affirmative. The data posted on clinicaltrials.gov demonstrates that this medical investigation, which was initially launched on May 4th 2023 is still recruiting patients. Approximately 20 people are being accepted at a single site for the study."
Answered by AI
How many participants is the research project accommodating?
"Affirmative. According to clinicaltrials.gov, this medical study is currently enrolling patients who meet the criteria. The trial was published on May 4th 2023 and updated lastly on May 15th 2023; it aims to recruit a total of 20 individuals from one centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger